Detalles de la búsqueda
1.
Safety and efficacy of cell-free and concentrated ascites reinfusion therapy against cirrhotic ascites in comparison with malignancy-related ascites.
J Gastroenterol Hepatol
; 36(11): 3224-3232, 2021 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-34250635
2.
Clinical usefulness of cell-free and concentrated ascites reinfusion therapy (CART) in combination with chemotherapy for malignant ascites: a post-marketing surveillance study.
Int J Clin Oncol
; 26(6): 1130-1138, 2021 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-33761026
3.
Cell-free and Concentrated Ascites Reinfusion Therapy for Refractory Ascites in Cirrhosis in Post-marketing Surveillance and the Role of Tolvaptan.
Intern Med
; 58(21): 3069-3075, 2019 Nov 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31292400
4.
Safety and efficacy of cell-free and concentrated ascites reinfusion therapy (CART) in refractory ascites: Post-marketing surveillance results.
PLoS One
; 12(5): e0177303, 2017.
Artículo
en Inglés
| MEDLINE | ID: mdl-28510606
Resultados
1 -
4
de 4
1
Próxima >
>>